Cargando…

Using SARS-CoV-2 Antibody Testing in COVID-19 Research

Detalles Bibliográficos
Autores principales:	Amraotkar, Alok R., Keith, Rachel J., Palmer, Kenneth E., Bhatnagar, Aruni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922202/ https://www.ncbi.nlm.nih.gov/pubmed/36780969 http://dx.doi.org/10.1016/j.amjmed.2023.02.001

Ejemplares similares

Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination
por: Amraotkar, Alok R., et al.
Publicado: (2022)

SARS-CoV-2 wastewater concentration and linked longitudinal seroprevalence: a spatial analysis of strain mutation, post-COVID-19 vaccination effect, and hospitalization burden forecasting
por: Holm, Rochelle H, et al.
Publicado: (2023)

Quantifying the relationship between sub-population wastewater samples and community-wide SARS-CoV-2 seroprevalence
por: Smith, Ted, et al.
Publicado: (2022)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
por: Greninger, Alexander L., et al.
Publicado: (2020)

Waning antibodies to SARS-CoV-2 – Don't panic
por: Meyer, Benjamin
Publicado: (2021)

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

Group Testing for SARS-CoV-2: Forward to the Past?
por: Pouwels, Koen B., et al.
Publicado: (2020)

Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
por: Owen, Sophie I., et al.
Publicado: (2022)

SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW
por: Plebani, Mario
Publicado: (2020)

Searching for escape-resistant anti–SARS-CoV-2 neutralizing antibodies
por: Mahla, Ranjeet Singh, et al.
Publicado: (2022)

Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus
Publicado: (2020)

My Experience with SARS-CoV-2, with a Focus on Testing
por: Cotter, Peggy A.
Publicado: (2020)

Evaluation of High-Throughput Serological Tests for SARS-CoV-2
por: Loeffelholz, Michael J.
Publicado: (2020)

Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing
por: Lau, Chin-Shern, et al.
Publicado: (2021)

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR—Facts and Fallacies
por: Bustin, Stephen, et al.
Publicado: (2021)

Abnormal liver blood tests among hospitalised patients with SARS-CoV2 (COVID-19)
por: Ruiz, Pablo, et al.
Publicado: (2020)

Practical problems and responses for SARS-CoV-2 laboratory testing during the COVID-19 pandemic
por: Tang, Julian W., et al.
Publicado: (2023)

RT-qPCR Testing of SARS-CoV-2: A Primer
por: Bustin, Stephen A., et al.
Publicado: (2020)

SARS-CoV-2/COVID-19 Testing: The Tower of Babel
por: Reno, Chiara, et al.
Publicado: (2020)

SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations
por: Wolfe, Ian D., et al.
Publicado: (2021)

Research progresses in vertical transmission of SARS-CoV-2 among infants born to mothers with COVID-19
por: Peng, Zhoujie, et al.
Publicado: (2022)

SARS‐CoV‐2 (COVID‐19) pandemic and a possible impact in the future of menstrual cycle research
por: Prado, Raul Cosme Ramos, et al.
Publicado: (2021)

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
por: Cohen, Samuel A., et al.
Publicado: (2020)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

The SARS-CoV-2 pandemic puts the spotlight on gender inequality in clinical research
por: Søgaard, Mette, et al.
Publicado: (2021)

SARS-CoV-2 testing in infertile patients: different recommendations in Europe and America
por: La Marca, Antonio, et al.
Publicado: (2020)

Detect to protect: pneumoperitoneum gas samples for SARS-CoV-2 and biohazard testing
por: Cicuttin, Enrico, et al.
Publicado: (2020)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

State of the Globe: Navigating the Impact of SARS-CoV-2 Mutations on COVID-19 Testing
por: Varshney, Rohit Kumar
Publicado: (2023)

Approach to Assessment of New Swabs and Viral Transport Media for SARS-CoV-2 Testing
por: Locher, Kerstin, et al.
Publicado: (2021)

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies
por: Gaspar, Emanuelle Baldo, et al.
Publicado: (2021)

Africa’s contribution to the science of the COVID-19/SARS-CoV-2 pandemic
por: Kana, Musa Abubakar, et al.
Publicado: (2021)

Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
por: Samet, Jonathan M
Publicado: (2020)

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
por: Cevik, Muge, et al.
Publicado: (2021)

When is the SARS-CoV-2 infection over and what is post-COVID?
por: Finsterer, Josef
Publicado: (2022)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0n2gjukmnkqt6me25sp3vek0bc